Research Topic · Peer-Reviewed

Amphotericin

Amphotericin is a powerful antifungal medication used in the treatment of life-threatening fungal infections. This drug is primarily used to treat infections caused by specific species of fungus, such as Aspergillus, Candida, Cryptococcus, and Histoplasma. Amphotericin is classified as a polyene macrolide antibioti…

Curated from this journal's research 📚 6 peer-reviewed articles cited Cited 58× across the literature 🔖 ISSN 2641-4538 🗓 Reviewed June 2026

Overview

Amphotericin is a powerful antifungal medication used in the treatment of life-threatening fungal infections. This drug is primarily used to treat infections caused by specific species of fungus, such as Aspergillus, Candida, Cryptococcus, and Histoplasma. Amphotericin is classified as a polyene macrolide antibiotic and works by binding to the fungal cell membrane, causing it to become more permeable and ultimately leading to cell death. As a result, Amphotericin has been proven to be highly effective in treating systemic fungal infections that are resistant to other antifungal agents. However, the use of this medication is not without side effects. The most common ones include fever, headache, chills, low blood pressure, muscle and joint pain, and nausea. In some cases, it may also cause skin reactions, liver toxicity, and other serious complications. Despite its side effects, Amphotericin remains a vital tool in the fight against life-threatening fungal infections, particularly in immunocompromised patients. If you suspect that you have a fungal infection, it is important to seek medical attention immediately for proper diagnosis and treatment. Early intervention is paramount in preventing complications and improving your chances of a full recovery.

Research published in this journal

6 peer-reviewed articles, ranked by relevance. Each links to its DOI.

How this research is being cited

The 6 articles above have been cited 58 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Jun 2026.

A sample of recent works citing this journal's research on Amphotericin, linking to each citing work.

Editorial oversight

Curated from peer-reviewed research published in Public Health International (ISSN 2641-4538).

Journal editorial board
Javad Javan-Noughabi · United Kingdom Evelyn O Talbott · United States Zainab Taha · United Arab Emirates

This page summarises published research for orientation; it is not medical or professional advice.